| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.2M | +1363.8% |
| R&D Expense | $6.6M | -10.6% |
| SG&A Expense | $42.6M | +6.7% |
| Operating Income | -$81.8M | +20.3% |
| Interest Expense | $2.2M | +85.2% |
| Net Income | -$66.2M | +32.4% |
| EPS (Basic) | -$0.28 | +36.4% |
| EPS (Diluted) | -$0.28 | +36.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $298.3M | +25.8% |
| Short-term Investments | $167.4M | +0.0% |
| Accounts Receivable | $2.6M | +451.1% |
| Inventory | $3.8M | -40.0% |
| Current Assets | $386.4M | -7.0% |
| Total Assets | $650.3M | -7.2% |
| Current Liabilities | $91.4M | +259.4% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.7M | -2.1% |
| Capital Expenditures | $54.5M | -28.1% |
| Investing Cash Flow | $114.1M | +22.2% |
| Financing Cash Flow | -$189K | -100.1% |
| Free Cash Flow | -$108.2M | +15.7% |
| Long-term Debt |
| $68.1M |
| +0.9% |
| Total Liabilities | $92.9M | -2.5% |
| Stockholders' Equity | $557.4M | -7.9% |